391 related articles for article (PubMed ID: 16838243)
1. Tigecycline: a critical analysis.
Stein GE; Craig WA
Clin Infect Dis; 2006 Aug; 43(4):518-24. PubMed ID: 16838243
[TBL] [Abstract][Full Text] [Related]
2. Tigecycline: first of a new class of antimicrobial agents.
Rose WE; Rybak MJ
Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
[TBL] [Abstract][Full Text] [Related]
3. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
Garrison MW; Neumiller JJ; Setter SM
Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline: a new glycylcycline for treatment of serious infections.
Noskin GA
Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.
Bradford PA; Weaver-Sands DT; Petersen PJ
Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070
[TBL] [Abstract][Full Text] [Related]
7. Tigecycline: a new glycylcycline antimicrobial.
Townsend ML; Pound MW; Drew RH
Int J Clin Pract; 2006 Dec; 60(12):1662-72. PubMed ID: 17109673
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent.
Meagher AK; Ambrose PG; Grasela TH; Ellis-Grosse EJ
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):165-71. PubMed ID: 16105560
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline: a novel glycylcycline antibiotic.
Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
11. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
[TBL] [Abstract][Full Text] [Related]
12. Tigecycline: a glycylcycline antimicrobial agent.
Doan TL; Fung HB; Mehta D; Riska PF
Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
[TBL] [Abstract][Full Text] [Related]
13. What role for tigecycline in infections?
BMJ Group
Drug Ther Bull; 2008 Aug; 46(8):62-4. PubMed ID: 18687585
[TBL] [Abstract][Full Text] [Related]
14. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
15. Tigecycline: a novel broad-spectrum antimicrobial.
Slover CM; Rodvold KA; Danziger LH
Ann Pharmacother; 2007 Jun; 41(6):965-72. PubMed ID: 17519296
[TBL] [Abstract][Full Text] [Related]
16. Tigecycline: in-vitro performance as a predictor of clinical efficacy.
Hawkey P; Finch R
Clin Microbiol Infect; 2007 Apr; 13(4):354-62. PubMed ID: 17359318
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline: what is it, and where should it be used?
Livermore DM
J Antimicrob Chemother; 2005 Oct; 56(4):611-4. PubMed ID: 16120626
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline.
Pankey GA
J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
Fraise AP
J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
